in

FDA Approves Ustekinumab Biosimilar Otulfi

Source link : https://www.newshealth.biz/health-news/fda-approves-ustekinumab-biosimilar-otulfi/

The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson’s ustekinumab (Stelara). This is the fourth ustekinumab biosimilar approved in the United States. Like the reference product, ustekinumab-aauz is indicated for: Patients 6 years or older with moderate to severe plaque psoriasis who are candidates for phototherapy or […]

Author : News Health

Publish date : 2024-10-01 18:48:29

Copyright for syndicated content belongs to the linked Source.

The Guardian view on Austria’s election: yet another wake-up call | Editorial

Cambodia Opens Its Doors to US Navy at New Port with China’s Support